Tango Therapeutics (TNGX) Net Margin: 2020-2025
Historic Net Margin for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to 29.52%.
- Tango Therapeutics' Net Margin rose 28081.00% to 29.52% in Q3 2025 from the same period last year, while for Sep 2025 it was -151.09%, marking a year-over-year increase of 13331.00%. This contributed to the annual value of -309.73% for FY2024, which is 3119.00% down from last year.
- According to the latest figures from Q3 2025, Tango Therapeutics' Net Margin is 29.52%, which was up 102.42% from -1,221.41% recorded in Q2 2025.
- Tango Therapeutics' Net Margin's 5-year high stood at 29.52% during Q3 2025, with a 5-year trough of -1,221.41% in Q2 2025.
- In the last 3 years, Tango Therapeutics' Net Margin had a median value of -485.74% in 2023 and averaged -473.88%.
- Per our database at Business Quant, Tango Therapeutics' Net Margin skyrocketed by 28,862bps in 2023 and then plummeted by 109,285bps in 2025.
- Tango Therapeutics' Net Margin (Quarterly) stood at -385.83% in 2021, then crashed by 6,817bps to -454.00% in 2022, then plummeted by 11,219bps to -566.19% in 2023, then crashed by 34,780bps to -913.99% in 2024, then soared by 28,081bps to 29.52% in 2025.
- Its last three reported values are 29.52% in Q3 2025, -1,221.41% for Q2 2025, and -739.54% during Q1 2025.